{"text": ["Why", "Rigel", "Pharmaceuticals", "Stock", "Is", "Jumping", "Today"], "created_at": "2021-02-18 17:40:00"}
{"text": ["Return", "On", "Capital", "Employed", "Overview:", "Eli", "Lilly"], "created_at": "2021-02-18 15:18:42"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Lily-Rigel", "Licensing", "Deal,", "vTv", "Starts", "Early", "Stage", "Psoriasis", "Study,", "Immunic", "Data", "Readout"], "created_at": "2021-02-18 13:14:37"}
{"text": ["UPDATE", "1-Eli", "Lilly", "in", "deal", "with", "Rigel", "to", "develop", "autoimmune", "therapy", "for", "up", "to", "$960", "mln"], "created_at": "2021-02-18 12:17:46"}
{"text": ["Rigel", "Pharma", "shares", "soar", "39%", "premarket", "on", "news", "of", "deal", "with", "Eli", "Lilly"], "created_at": "2021-02-18 11:52:00"}
{"text": ["Lilly", "and", "Rigel", "Enter", "Strategic", "Collaboration", "to", "Develop", "RIPK1", "Inhibitors", "for", "the", "Potential", "Treatment", "of", "Immunological", "and", "Neurodegenerative", "Diseases"], "created_at": "2021-02-18 11:30:00"}
{"text": ["Rigel", "Pharmaceuticals", "Rises", "on", "Drug", "Venture", "With", "Eli", "Lilly"], "created_at": "2021-02-18 09:35:00"}
{"text": ["Rigel", "Higher", "on", "Immunology-Drug", "Venture", "With", "Eli", "Lilly"], "created_at": "2021-02-18 08:34:00"}
